CG
Clarus Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Buy |
2,222
+6
| +0.3% | +$1.11K | 0.15% | 61 |
|
|
2025
Q1 | $464K | Buy |
2,216
+44
| +2% | +$9.22K | 0.18% | 54 |
|
|
2024
Q4 | $386K | Sell |
2,172
-447
| -17% | -$79.4K | 0.14% | 69 |
|
|
2024
Q3 | $517K | Sell |
2,619
-133
| -5% | -$26.3K | 0.22% | 50 |
|
|
2024
Q2 | $472K | Sell |
2,752
-742
| -21% | -$127K | 0.21% | 62 |
|
|
2024
Q1 | $636K | Buy |
3,494
+7
| +0.2% | +$1.28K | 0.45% | 39 |
|
|
2023
Q4 | $540K | Sell |
3,487
-490
| -12% | -$75.9K | 0.41% | 46 |
|
|
2023
Q3 | $593K | Sell |
3,977
-269
| -6% | -$40.1K | 0.43% | 46 |
|
|
2023
Q2 | $572K | Buy |
4,246
+491
| +13% | +$66.2K | 0.42% | 39 |
|
|
2023
Q1 | $598K | Buy |
3,755
+106
| +3% | +$16.9K | 0.56% | 28 |
|
|
2022
Q4 | $590K | Sell |
3,649
-554
| -13% | -$89.5K | 0.52% | 32 |
|
|
2022
Q3 | $564K | Buy |
4,203
+6
| +0.1% | +$805 | 0.51% | 32 |
|
|
2022
Q2 | $643K | Buy |
4,197
+6
| +0.1% | +$919 | 0.54% | 31 |
|
|
2022
Q1 | $679K | Sell |
4,191
-92
| -2% | -$14.9K | 0.46% | 33 |
|
|
2021
Q4 | $494K | Buy |
4,283
+8
| +0.2% | +$923 | 0.33% | 44 |
|
|
2021
Q3 | $461K | Sell |
4,275
-40
| -0.9% | -$4.31K | 0.32% | 45 |
|
|
2021
Q2 | $503K | Sell |
4,315
-100
| -2% | -$11.7K | 0.38% | 40 |
|
|
2021
Q1 | $465K | Buy |
4,415
+565
| +15% | +$59.5K | 0.39% | 44 |
|
|
2020
Q4 | $402K | Buy |
+3,850
| New | +$402K | 0.35% | 50 |
|